SCHEMBL4948347

SCHEMBL4948347

O=C(O)[C@H]1CCC2OC2C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TFPI2 P48307 5/20 0.52
LMNA P02545 2/20 0.52
KDM4E B2RXH2 1/20 0.52
GMNN O75496 1/20 0.52
PMP22 Q01453 1/20 0.52
TP53 P04637 1/20 0.52
TSHR P16473 1/20 0.52
NFKB1 P19838 1/20 0.52
THPO P40225 1/20 0.52
ACE P12821 1/20 0.41
PPM1B O75688 2/20 0.39
PTPN1 P18031 2/20 0.39
PPP1CC P36873 2/20 0.39
AKR1C3 P42330 1/20 0.39
AKR1C1 Q04828 1/20 0.39
GABRR1 P24046 1/20 0.39
PPP5C P53041 2/20 0.38
PPP2CA P67775 1/20 0.38
NPY4R P50391 1/20 0.38
PLG P00747 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2184711 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL4098788 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL4088843 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL4359618 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL7263479 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL2726787 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL4109815 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL124941 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL2184024 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22
SCHEMBL27976167 1.00 TFPI2 (0.52) TFPI2LMNAKDM4EGMNNPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365205-B2 Cyclic diamine derivatives useful as agents for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism; inhibit activated blood coagulation factor X DAIICHI SANKYO COMPANY, LIMITED (JP) 2008-04-29 US disclosed